$183.96 -$0.27 (-0.1%)

04:00 PM EST on 12/06/19

Insulet Corp (NASDAQ:PODD)

CAPS Rating: 4 out of 5

Dvlp,mftr,mkt insulin infusion system for diabetes

Current Price $183.96 Mkt Cap $11.4B
Open $186.33 P/E Ratio 665.31
Prev. Close $184.23 Div. (Yield) $0.00 (0.0%)
Daily Range $183.49 - $186.97 Volume 363,201
52-Wk Range $70.80 - $187.25 Avg. Daily Vol. 858,147

Caps

How do you think NASDAQ:PODD will perform against the market?

Add Stock to CAPS Watchlist

All Players

115 Outperform
40 Underperform
 

All-Star Players

39 Outperform
9 Underperform
 

Wall Street

9 Outperform
2 Underperform
 

Top NASDAQ:PODD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

BACnumber1 (< 20)
Submitted February 13, 2010

Watch Supersize Me. Once you watch the whole movie, you'll know why this stock is poised for greatness along with any other insulin provider

delos2 (< 20)
Submitted August 11, 2008

Not a market guy, but a manufacturing guy. Insulet was my account up until last year when the printed circuit board company I worked for finally gave up to offshore pressure. I knew a lot of these guys and I am amazed this company has not taken off… More

Recent Community Commentary

Read the most recent pitches from players about PODD.

Recs

0
Member Avatar Reybe (< 20) Submitted: 9/25/2019 9:38:26 PM : Outperform Start Price: $164.17 NASDAQ:PODD Score: +6.27

Diabetes. Has a technical advantage.

Recs

0
Member Avatar TMFEBCapital (86.35) Submitted: 10/25/2018 10:14:02 AM : Outperform Start Price: $84.42 NASDAQ:PODD Score: +100.59

Demand for Insulet's wireless insulin pump, Omnipod, could slip short-term because of Tandem Diabetes automated insulin system, but I expect a similar system to become available from Insulet soon and if so, then its flexible design and loyal customer base could drive adoption in most type 1 patients, plus many insulin intensive type 2 patients (over time).

Recs

0
Member Avatar NHWeston102 (71.83) Submitted: 8/4/2016 11:33:38 AM : Outperform Start Price: $42.20 NASDAQ:PODD Score: +290.49

Moving into a take-off point with a simple semi-artificial pancreas device that will be highly competitive with Medtronics, JNJ, Tandem and others in this space. In the "Internet-of-Things", you, too, is a "thing."

Leaderboard

Find the members with the highest scoring picks in PODD.

Score Leader

SheepInvstr321

SheepInvstr321 (95.32) Score: +4,000.56

The Score Leader is the player with the highest score across all their picks in PODD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SheepInvstr321 95.32 4/15/2009 Outperform 5Y $4.20 +4,280.00% +276.22% +4,003.78 0 Comment
billwdude 96.16 11/17/2008 Outperform 5Y $4.29 +4,188.11% +273.94% +3,914.17 1 Comment
UnderTenBucks 87.42 5/4/2009 Outperform NS $5.78 +3,082.70% +259.28% +2,823.42 0 Comment
SSPX4 96.71 5/4/2009 Outperform NS $5.78 +3,082.70% +259.28% +2,823.42 0 Comment
rogbob1 95.52 5/26/2009 Outperform 5Y $6.62 +2,678.85% +260.03% +2,418.82 0 Comment
SSPX911 97.14 5/14/2009 Outperform NS $6.75 +2,625.33% +258.57% +2,366.76 0 Comment
MaximumDamage 82.25 5/18/2009 Outperform NS $6.85 +2,585.55% +255.25% +2,330.30 0 Comment
SSPX8 73.45 6/8/2009 Outperform 5Y $7.34 +2,406.27% +239.01% +2,167.26 0 Comment
SSPX0 72.95 6/8/2009 Outperform 5Y $7.34 +2,406.27% +239.01% +2,167.26 0 Comment
freedomfrys 37.37 6/5/2009 Outperform 5Y $7.45 +2,369.26% +238.17% +2,131.09 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PODD.